ATE216777T1 - Affinitäts-selektion von liganden mittels massenspektroskopie - Google Patents

Affinitäts-selektion von liganden mittels massenspektroskopie

Info

Publication number
ATE216777T1
ATE216777T1 AT96906169T AT96906169T ATE216777T1 AT E216777 T1 ATE216777 T1 AT E216777T1 AT 96906169 T AT96906169 T AT 96906169T AT 96906169 T AT96906169 T AT 96906169T AT E216777 T1 ATE216777 T1 AT E216777T1
Authority
AT
Austria
Prior art keywords
mass spectroscopy
ligands
affinity selection
target
compound
Prior art date
Application number
AT96906169T
Other languages
English (en)
Inventor
Gavin D Dollinger
Verena D Huebner
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE216777T1 publication Critical patent/ATE216777T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT96906169T 1995-01-19 1996-01-16 Affinitäts-selektion von liganden mittels massenspektroskopie ATE216777T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/375,979 US5891742A (en) 1995-01-19 1995-01-19 Affinity selection of ligands by mass spectroscopy
PCT/US1996/000575 WO1996022530A1 (en) 1995-01-19 1996-01-16 Affinity selection of ligands by mass spectroscopy

Publications (1)

Publication Number Publication Date
ATE216777T1 true ATE216777T1 (de) 2002-05-15

Family

ID=23483180

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96906169T ATE216777T1 (de) 1995-01-19 1996-01-16 Affinitäts-selektion von liganden mittels massenspektroskopie

Country Status (8)

Country Link
US (1) US5891742A (de)
EP (1) EP0804729B1 (de)
JP (1) JP3422493B2 (de)
AT (1) ATE216777T1 (de)
AU (1) AU4963796A (de)
CA (1) CA2209988C (de)
DE (1) DE69620870T2 (de)
WO (1) WO1996022530A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063633A (en) 1996-02-28 2000-05-16 The University Of Houston Catalyst testing process and apparatus
WO1997043301A2 (en) * 1996-05-10 1997-11-20 Novartis Ag Identification of members of combinatorial libraries by mass spectrometry
EP1669738A3 (de) * 1996-10-09 2007-12-12 Symyx Technologies, Inc. Infrarotspektroskopie und Abbildung von Bibliotheken
US6528098B2 (en) * 1996-10-22 2003-03-04 Advanced Viral Research Corp. Preparation of a therapeutic composition
DE19649359C1 (de) * 1996-11-28 1998-02-12 Thomas Prof Dr Peters Verfahren zum Nachweis biologisch aktiver Substanzen in Substanzbibliotheken
JP2002505004A (ja) * 1997-06-13 2002-02-12 バーテックス ファマシューティカルズ インコーポレイテッド 薬剤核を同定する方法
WO1999029908A1 (en) * 1997-12-11 1999-06-17 The President & Fellows Of Harvard College A method for identifying new anti-picornaviral compounds
EP2241542A1 (de) 1998-01-05 2010-10-20 Neogenesis, Inc. Vorrichtung zur Herstellung von massen-kodierten kombinatorischen Bibliotheken
US6207861B1 (en) 1998-01-05 2001-03-27 Neogenesis, Inc. Method for producing and screening mass coded combinatorial libraries for drug discovery and target validation
JP3788909B2 (ja) 1999-02-12 2006-06-21 セテク コーポレイション 親和力配位子について複合生理学的材料をスクリーニングする高処理量のサイズ排除法
MXPA02008253A (es) * 2000-02-25 2002-11-29 Wyeth Corp Metodos de diseno de farmacos basados en la estructura usando em/rmn.
DE10028186A1 (de) * 2000-06-09 2002-09-19 November Ag Molekulare Medizin Verfahren zur Bestimmung der Menge von an Ziel-Molekülen gebundenen Liganden
US6864091B1 (en) 2000-08-31 2005-03-08 Symyx Technologies, Inc. Sampling probe
JP2004534519A (ja) * 2000-11-17 2004-11-18 アルフレッド イー. スランツ 標的分子機能の決定と薬物リード化合物の同定に関する方法
DE10125258A1 (de) * 2001-05-23 2003-01-09 November Ag Molekulare Medizin Verfahren zur Bestimmung des Bindeverhaltens von an Ziel-Molekülen spezifisch bindenden Liganden
WO2004037848A2 (en) * 2002-05-17 2004-05-06 Slanetz Alfred E Process for determining target function and identifying drug leads
MXPA05009723A (es) * 2003-03-10 2006-02-17 Schering Corp Analisis de ligando.
DE10327399A1 (de) * 2003-06-18 2005-01-05 Carl Zeiss Jena Gmbh Verfahren und Messanordnung zur markierungsfreien Detektion von Bindungsereignissen zwischen Proteinen und oberflächengebundenen Antikörpern
DE102005022057B3 (de) * 2005-05-09 2007-02-08 Analyticon Biotechnologies Ag Verfahren zur Herstellung von Liganden, Liganden und Test-Kit
AU2005332686B2 (en) * 2005-06-03 2012-09-27 Ohr Pharmaceutical, Inc. Methods for providing palliative care with AVR118
CA2634821C (en) * 2005-12-23 2016-05-03 Andrew Emili Method for the identification of macromolecule targets of analytes
WO2007079755A1 (en) 2006-01-12 2007-07-19 Janus Beierholm Holding Aps Reimmunization and antibody design
PL2027158T3 (pl) 2006-05-02 2013-02-28 Carviar Aps Sposób immunizacji gatunków ptaków
AU2020344959A1 (en) 2019-09-13 2022-01-27 Eurofins Cerep Methods for using mass spectroscopy in multiplex target evaluations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022876A (en) * 1973-06-21 1977-05-10 Stanford Research Institute Mass spectrometric immunoassay
IL49685A (en) * 1976-05-31 1978-10-31 Technion Res & Dev Foundation Specific binding assay method for determining the concentration of materials and reagent means therefor
DE3417638A1 (de) * 1984-05-10 1985-11-14 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur bestimmung geringer stoffmengen von arzneimitteln, von koerpereigenen oder anderen chemischen substanzen in biologischem material
US4586108A (en) * 1984-10-12 1986-04-29 Rosemount Inc. Circuit for capacitive sensor made of brittle material
US5182366A (en) * 1990-05-15 1993-01-26 Huebner Verena D Controlled synthesis of peptide mixtures using mixed resins
IE66205B1 (en) * 1990-06-14 1995-12-13 Paul A Bartlett Polypeptide analogs
US5470753A (en) * 1992-09-03 1995-11-28 Selectide Corporation Peptide sequencing using mass spectrometry
WO1994006451A1 (en) * 1992-09-24 1994-03-31 Chiron Corporation Synthesis of n-substituted oligomers
DE69432608T2 (de) * 1993-06-01 2004-02-26 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Expression von inhibitoren vom plasminogenaktivator vom urokinasetyp
GB9315847D0 (en) * 1993-07-30 1993-09-15 Isis Innovation Tag reagent and assay method
WO1995025737A1 (en) * 1994-03-23 1995-09-28 The Penn State Research Foundation Method for identifying members of combinatorial libraries

Also Published As

Publication number Publication date
CA2209988A1 (en) 1996-07-25
EP0804729B1 (de) 2002-04-24
US5891742A (en) 1999-04-06
CA2209988C (en) 2005-01-04
JPH10512673A (ja) 1998-12-02
EP0804729A1 (de) 1997-11-05
AU4963796A (en) 1996-08-07
DE69620870D1 (de) 2002-06-06
JP3422493B2 (ja) 2003-06-30
WO1996022530A1 (en) 1996-07-25
DE69620870T2 (de) 2002-08-14

Similar Documents

Publication Publication Date Title
ATE216777T1 (de) Affinitäts-selektion von liganden mittels massenspektroskopie
ATE215228T1 (de) Gerät zur untersuchung von verbindungssammlungen
DK0839152T3 (da) Kombinatoriske biblioteker af mærkede, biokemiske forbindelser og fremgangsmåde til fremstilling af disse
Brown Jr et al. The ecological activity of alkaloids
WO2004062553A3 (en) Affinity screening using “one-bead-one-compound” libraries
ATE343791T1 (de) Verfahren zur sichtung einer bibliothek von chemischen verbindungen
Geoghegan et al. Biochemical applications of mass spectrometry in pharmaceutical drug discovery
CA2653517A1 (en) Process of designing a drug
DE69433114D1 (de) Metallion-ligand koordinationskomplexe, antikorper dagegen und tests die solche antikorper verwenden
CA2326341A1 (en) Pharmacophore recombination for the identification of small molecule drug lead compounds
DK1479771T3 (da) Fremgangsmåde til at screene fag-visningsbiblioteker med forskellige ligander
NO903717D0 (no) Fremgangsmaate ved analyse av en underjordisk proeve.
ATE489108T1 (de) Flt4 (vegfr-3) als ziel für tumornachweis (imaging) und antitumortherapie
DK0868427T3 (da) Fremgangsmåder til at idenficere forbindelser, der binder til et mål
Wilkins Hyphenated techniques for analysis of complex organic mixtures
Doerge et al. Quantitative analysis of 4-aminobiphenyl-C8-deoxyguanosyl DNA adducts produced in vitro and in vivo using HPLC–ES-MS
DE69613146D1 (de) Verwendung von kernspinresonanz zur bestimmung von liganden für zielbiomoleküle
WO1997043301A3 (en) Identification of members of combinatorial libraries by mass spectrometry
DK0985678T3 (da) Kombinatorisk syntese og analyse af organometalliske forbindelser og katalysatorer
Basu et al. Quantitative proteomics and applications in covalent ligand discovery
CA2329818A1 (en) Method for analyzing total reactive sulfur
Pap et al. Assessing the reproducibility of an O‐glycopeptide enrichment method with a novel software, Pinnacle
RU2076310C1 (ru) Способ количественного спектрального анализа многокомпонентных веществ
Tsuchiya et al. Identification of chemical compounds by computer matching of low resolution mass spectra and retention indices
CA2237336A1 (en) Use of nuclear magnetic resonance to design ligands to target biomolecules

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties